PHGE

Conviction 12HealthcareScan · Thu, Jun 25, 2026

PHGE$0.3996-4.06%

ResistanceSupportVol 14

Vol MA14 1.29M

Mar 26Apr 14May 1May 19Jun 8Jun 25

BiomX Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.biomx.com ↗

Price0.3996

Change-4.06%

Gap+2.62%

Rel volume0.04×

Avg volume1.45M

Avg $ vol1.2M

SMA 200.7194

SMA 500.8695

SMA 2002.30

Price vs 50-54.04%

Price vs 200-82.59%

MA stackbearish

50/200 cross—

Supertrenddown · 0.7531

RSI (14)33

MACD hist-0.00

MACD crossbear · 3d

Stoch %K / %D0 / 2

ADX (14)17

+DI / −DI21 / 32

RSI divergence—

MACD divergence—

ATR %+35.77%

ADR %16.04%

52w high7.50

52w low0.2550

From 52w high-94.67%

Above 52w low+56.71%

New 52w highNo

SqueezeOff

Bollinger width160.32%

%B0.22

Donchian pos0.00%

Donchian high1.89

Donchian low0.3996

AVWAP (52w high)0.8941

vs AVWAP high-55.31%

AVWAP (52w low)1.55

vs AVWAP low-74.23%

OBV trendDown

Chaikin MF (20)-0.60

Today vs 20d0.04×

Avg vol (14d)1.29M

Avg vol (20d)1.45M

Avg $ vol (20d)1.2M

Market cap4.05M

RS 3m (vs SPY)-103.69%

RS 6m (vs SPY)-88.18%

RS line new highNo

Trend template3/8

Technical rank1.5

1 week-27.35%

1 month-75.33%

3 months-91.83%

6 months-81.75%

1 year-18.28%

YTD-81.33%

P/E-0.11

P/B-4.60

P/S—

P/FCF-0.15

EPS22.19

Div yield—

ROE—

ROA—

Debt/Eq-12.70

Current1.24

EV/EBITDA-0.33

Gross margin—

Net margin—

Rev growth—

EPS growth-104.20%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value14.07M

Revenue—

Net income-19.14M

Gross profit—

Free cash flow-26.39M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNYSE

Shares out11.16M

Employees20

ListedWed, Mar 13, 2019

Free float3.7M

Float %56.5%

Short interest594.28K

Days to cover0.0d

Short volume35.5%

Squeeze score32 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction12 / 100

Pattern quality—

Tech rank1.5 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.31

Support0.4386

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PHGE

All disclosures →

No recent disclosed trades by Congress in PHGE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PHGE

No recent insider (Form 4) filings in PHGE. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in PHGE · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.